March 2013 Fosamax Product Liability Litigation Update: Femur Fracture Cases Against Merck

December 31, 2012 Totals: 2,075 New Jersey (NJ) State Court Lawsuits, With 820 Cases Pending In Federal Court Fosamax MDL And 420 California Claims

(Posted by at DrugInjuryWatch.com)

______________________________________________________________________________

UPDATE: "Second Fosamax – Femur Fracture Lawsuit Trial Starts In New Jersey, This One In The Federal Court MDL With Judge Pisano Presiding"

(4/8/13)

______________________________________________________________________________

The first Fosamax – femur fracture trial, Su v. Merck, starts today (March 11, 2013) in a New Jersey (NJ) state court.

From the Merck 2012 Annual Report / Form 10-K (PDF) we get this information about the NJ state court Fosamax litigation:

As of December 31, 2012, approximately 2,075 cases alleging Femur Fractures have been filed in New Jersey state court and are pending before Judge Higbee in Atlantic County Superior Court. The parties have selected an initial group of 30 cases to be reviewed through fact discovery.

The federal court Fosamax multidistrict (MDL) for femur fracture cases was created in May 2011 and the first trial in that litigation is currently scheduled to start in April 2013.

_____________________________________________________________________

 

Free Fosamax Case Evaluation 

Strictly Confidential, No Obligation.

______________________________________________________________________________

From the Merck 2012 Annual Report here is what the drug company reports about this federal court MDL Fosamax litigation:

[A]pproximately 820 cases were pending in the Fosamax Femur Fracture MDL as of December 31, 2012. A Case Management Order has been entered that requires the parties to review 40 cases (later reduced to 33 cases). Judge Joel Pisano has selected four cases from that group to be tried as the initial bellwether cases in the Fosamax Femur Fracture MDL and has set an April 8, 2013 trial date for the first bellwether case, which will be Glynn v. Merck. The Zessin v. Merck case is set to be tried in September 2013; the Young v. Merck case is set to be tried in January 2014; and the Johnson v. Merck case is set to be tried in May 2014.

Lastly, out west, at the end of December 2012 there were 420 California state court lawsuits alleging femur fractures caused by Fosamax use. The consolidated proceedings for those California cases is situated in Orange County, with Judge Steven Perk presiding.

Be assured that we are watching for the Su v. Merck trial jury verdict in New Jersey and we will continue to monitor each of the three Fosamax litigations — NJ, MDL, and CA.

______________________________________________________________________________

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects  (All website content by attorney Tom Lamb)

Drug Injury Case Evaluation – Free & Confidential  (Review done by attorney Tom Lamb)

2 responses to “March 2013 Fosamax Product Liability Litigation Update: Femur Fracture Cases Against Merck”

  1. PeggyFoley Avatar
    PeggyFoley

    Is there any update on the lawsuits regarding the unexplained femur fractures.
    Peggy H. Foley

  2. Tom Lamb Avatar

    Here is my most recent article about the Fosamax litigation, from June 2015:
    Fosamax – Femur Fracture Lawsuits Update: California Verdict For Merck In April 2015 With Two More California Trials Scheduled For July 2015 And October 2015
    http://www.druginjurylaw.com/2015/06/18/fosamax-femur-fracture-lawsuits-update-california-verdict-for-merck-in-april-2015-with-two-more-california-trials-scheduled-for-july-2015-and-october-2015/
    Let me know if you have any questions.
    Tom Lamb

Leave a Reply

Your email address will not be published. Required fields are marked *